EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
Émilie Le Rhun(University of Zurich), Matthias Preusser(Medical University of Vienna), Rolf A. Stahel(International Breast Cancer Study Group), Michael Weller(University Hospital of Zurich), Matthias Gückenberger(University Hospital of Zurich), Anna S. Berghoff(Medical University of Vienna), Dirk Schadendorf(National Center for Tumor Diseases), Thomas Bachelot(Centre Léon Bérard), Marion Smits(Erasmus MC), Philippe Métellus(Centre National de la Recherche Scientifique), Norbert Galldiks(Forschungszentrum Jülich), Pieter Wesseling(Radboud University Nijmegen), Solange Peters(University Hospital of Lausanne), Felix Sahm(German Cancer Research Center), Joan Seoane(Institució Catalana de Recerca i Estudis Avançats), Giuseppe Minniti(Istituto Neurologico Mediterraneo), Evandro de Azambuja(Université Libre de Bruxelles), Reinhard Dummer(University Hospital of Zurich), Martin J. van den Bent(Erasmus MC Cancer Institute), Yuna Hong(The Catholic University of Korea Seoul St. Mary's Hospital), Frank Winkler(German Cancer Research Center)
Cited by 577
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
|Annals of Oncology|2018|2.9k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2017|2.4k